Advances in MET tyrosine kinase inhibitors in gastric cancer

Gastric cancer is among the most frequently occurring cancers and a leading cause of cancer-related deaths globally. Because gastric cancer is highly heterogenous and comprised of different subtypes with distinct molecular and clinical characteristics, the management of gastric cancer calls for bett...

Full description

Bibliographic Details

Published in:	Cancer Biology & Medicine
Main Authors:	Yifan Zhang, Lin Shen, Zhi Peng
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2024-06-01
Subjects:	gastric cancer met alterations met tyrosine kinase inhibitors savolitinib met testing
Online Access:	https://www.cancerbiomed.org/content/21/6/484